Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Updates in adjuvant systemic therapy for melanoma.

Kwak M, Farrow NE, Salama AKS, Mosca PJ, Hanks BA, Slingluff CL, Beasley GM.

J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25298. [Epub ahead of print] Review.

PMID:
30481375
2.

Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma.

Zhao F, Evans K, Xiao C, DeVito N, Theivanthiran B, Holtzhausen A, Siska PJ, Blobe GC, Hanks BA.

Cancer Immunol Res. 2018 Dec;6(12):1459-1471. doi: 10.1158/2326-6066.CIR-18-0086. Epub 2018 Sep 12.

PMID:
30209062
3.

Life in the fast lane: Settled pastoralism in the Central Eurasian Steppe during the Middle Bronze Age.

Judd MA, Walker JL, Ventresca Miller A, Razhev D, Epimakhov AV, Hanks BK.

Am J Hum Biol. 2018 Jul;30(4):e23129. doi: 10.1002/ajhb.23129. Epub 2018 Apr 19.

PMID:
29672992
4.

Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.

Zhao F, Xiao C, Evans KS, Theivanthiran T, DeVito N, Holtzhausen A, Liu J, Liu X, Boczkowski D, Nair S, Locasale JW, Hanks BA.

Immunity. 2018 Jan 16;48(1):147-160.e7. doi: 10.1016/j.immuni.2017.12.004.

PMID:
29343435
5.

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.

J Immunother Cancer. 2017 May 16;5:44. doi: 10.1186/s40425-017-0243-4. eCollection 2017. Review.

6.

Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy.

Lowe JR, Perry DJ, Salama AK, Mathews CE, Moss LG, Hanks BA.

J Immunother Cancer. 2016 Dec 20;4:89. doi: 10.1186/s40425-016-0196-z. eCollection 2016.

7.

Weaning practices among pastoralists: New evidence of infant feeding patterns from Bronze Age Eurasia.

Ventresca Miller A, Hanks BK, Judd M, Epimakhov A, Razhev D.

Am J Phys Anthropol. 2017 Mar;162(3):409-422. doi: 10.1002/ajpa.23126. Epub 2016 Oct 31.

PMID:
27796036
8.

CRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjection.

Sessions JW, Skousen CS, Price KD, Hanks BW, Hope S, Alder JK, Jensen BD.

Springerplus. 2016 Sep 9;5(1):1521. doi: 10.1186/s40064-016-3037-0. eCollection 2016.

9.

Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab.

Qin R, Olson A, Singh B, Thomas S, Wolf S, Bhavsar NA, Hanks BA, Salama JK, Salama AK.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):72-7. doi: 10.1016/j.ijrobp.2016.04.017. Epub 2016 Apr 21.

PMID:
27375168
10.
11.

Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.

Barina AR, Bashir MR, Howard BA, Hanks BA, Salama AK, Jaffe TA.

Abdom Radiol (NY). 2016 Feb;41(2):207-14. doi: 10.1007/s00261-015-0560-3.

PMID:
26867901
12.

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.

Holtzhausen A, Zhao F, Evans KS, Tsutsui M, Orabona C, Tyler DS, Hanks BA.

Cancer Immunol Res. 2015 Sep;3(9):1082-95. doi: 10.1158/2326-6066.CIR-14-0167. Epub 2015 Jun 3.

13.

Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis.

Bostwick AD, Salama AK, Hanks BA.

J Immunother Cancer. 2015 May 19;3:19. doi: 10.1186/s40425-015-0064-2. eCollection 2015.

14.
15.

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma.

Jiang BS, Beasley GM, Speicher PJ, Mosca PJ, Morse MA, Hanks B, Salama A, Tyler DS.

Ann Surg Oncol. 2014 Aug;21(8):2525-31. doi: 10.1245/s10434-014-3671-0. Epub 2014 Apr 4.

16.

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

Hanks BA, Holtzhausen A, Evans KS, Jamieson R, Gimpel P, Campbell OM, Hector-Greene M, Sun L, Tewari A, George A, Starr M, Nixon A, Augustine C, Beasley G, Tyler DS, Osada T, Morse MA, Ling L, Lyerly HK, Blobe GC.

J Clin Invest. 2013 Sep;123(9):3925-40. doi: 10.1172/JCI65745. Epub 2013 Aug 8.

17.

Copper toxicosis in New Zealand White rabbits (Oryctolagus cuniculus).

Ramirez CJ, Kim DY, Hanks BC, Evans TJ.

Vet Pathol. 2013 Nov;50(6):1135-8. doi: 10.1177/0300985813490756. Epub 2013 May 22.

PMID:
23697481
18.

Reconstructing the origin and spread of horse domestication in the Eurasian steppe.

Warmuth V, Eriksson A, Bower MA, Barker G, Barrett E, Hanks BK, Li S, Lomitashvili D, Ochir-Goryaeva M, Sizonov GV, Soyonov V, Manica A.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8202-6. doi: 10.1073/pnas.1111122109. Epub 2012 May 7.

19.

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.

Morse MA, Hanks BA, Suhocki P, Doan PL, Liu EA, Frost P, Bernard SA, Tsai A, Moore DT, O'Neil BH.

Clin Colorectal Cancer. 2012 Sep;11(3):185-90. doi: 10.1016/j.clcc.2011.11.003. Epub 2012 Jan 26.

PMID:
22280845
20.

Pharmacological inhibition of TGFβ as a strategy to augment the antitumor immune response.

Hanks BA, Morse MA.

Curr Opin Investig Drugs. 2010 Dec;11(12):1342-53. Review.

PMID:
21154116
21.
22.

Diploid-triploid mosaicism and tissue ploidy diversity within Platemys platycephala from Suriname.

Bickham JW, Hanks BG.

Cytogenet Genome Res. 2009;127(2-4):280-6. doi: 10.1159/000297716. Epub 2010 Mar 17.

PMID:
20234128
23.

Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation.

Lapteva N, Seethammagari MR, Hanks BA, Jiang J, Levitt JM, Slawin KM, Spencer DM.

Cancer Res. 2007 Nov 1;67(21):10528-37.

24.

Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo.

Hanks BA, Jiang J, Singh RA, Song W, Barry M, Huls MH, Slawin KM, Spencer DM.

Nat Med. 2005 Feb;11(2):130-7. Epub 2005 Jan 23.

PMID:
15665830
25.
26.

Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.

Soman KV, Hanks BA, Tien H, Chari MV, O'Neal KD, Morrisett JD.

Protein Sci. 1997 May;6(5):999-1008.

27.

Comparison of the functional differences for the homologous residues within the carboxy phosphate and carbamate domains of carbamoyl phosphate synthetase.

Javid-Majd F, Stapleton MA, Harmon MF, Hanks BA, Mullins LS, Raushel FM.

Biochemistry. 1996 Nov 12;35(45):14362-9.

PMID:
8916923
28.

Role of conserved residues within the carboxy phosphate domain of carbamoyl phosphate synthetase.

Stapleton MA, Javid-Majd F, Harmon MF, Hanks BA, Grahmann JL, Mullins LS, Raushel FM.

Biochemistry. 1996 Nov 12;35(45):14352-61.

PMID:
8916922
29.

Centriolar length variability in testicular cells from side-necked turtles.

Hale DW, Hanks BG, Bickham JW, Greenbaum IF.

J Submicrosc Cytol Pathol. 1989 Jan;21(1):211-4.

PMID:
2702611
30.

Flow cytometric analysis of the effects of low-level radiation exposure on natural populations of slider turtles (Pseudemys scripta).

Bickham JW, Hanks BG, Smolen MJ, Lamb T, Gibbons JW.

Arch Environ Contam Toxicol. 1988 Nov;17(6):837-41. No abstract available.

PMID:
3228299
32.

Career ladder encourages better nursing care.

Hanks BJ.

Mich Hosp. 1983 Sep;19(9):17-9. No abstract available.

PMID:
10262437
33.

Gastrointestinal complications after cardiopulmonary bypass.

Hanks JB, Curtis SE, Hanks BB, Andersen DK, Cox JL, Jones RS.

Surgery. 1982 Aug;92(2):394-400.

PMID:
6980493
34.

Mechanics and energetics of lengthening of active airway smooth muscle.

Hanks BS, Stephens NL.

Am J Physiol. 1981 Jul;241(1):C42-6.

PMID:
7246762

Supplemental Content

Support Center